动脉样硬化中的微循环功能障碍:氧化,氧化应激和炎症的影响
Marta Aleksandrowicz1, Marek Konop2, Mateusz Rybka2
1Laboratory of Preclinical Research and Environmental Agents, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 A. Pawińskiego Street, 02-106 Warsaw, Poland.
International journal of molecular sciences
|July 12, 2025
概括
动脉样硬化 (AS),心血管疾病 (CVD) 的主要原因,源于内皮功能障碍. 像高血压 (HT) 和高脂血症 (HPL) 这样的关键危险因素会破坏氧化 (NO) 的产生,推动AS的进展.
科学领域:
- 心血管医学 心血管医学
- 病理生理学 病理生理学
- 血管生物学 血管生物学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,动脉样硬化 (AS) 是主要的潜在病理.
- 高血压 (HT),高脂血症 (HPL) 和高血糖 (HG) 是重要的公共卫生问题和心血管疾病的主要风险因素,通常与内皮功能障碍 (ED) 相关.
- 内皮细胞对血管健康至关重要,其功能障碍对AS的开始和进展至关重要.
研究的目的:
- 综合了解多因素相关动脉样硬化 (AS) 的病理生理学的最新进展.
- 探索内皮功能障碍 (ED) 的作用及其与AS发展中的关键风险因素的关系.
- 突出氧化 (NO) 生物可用性在维持血管平衡和其在AS中的破坏方面的重要性.
主要方法:
- 本综述综合了关于动脉样硬化的病理生理学的当前研究.
- 它研究了风险因素 (HT,HPL,HG) 与内皮细胞功能之间的相互作用.
- 该评论讨论了氧化应激,炎症和氧化 (NO) 在AS病变发生中的作用.
主要成果:
- 内皮功能障碍 (ED) 是动脉样硬化 (AS) 的发展和进展的一个关键因素.
- 高血压 (HT),高脂血症 (HPL) 和高血糖 (HG) 等危险因素有助于ED和AS.
- 氧化氧化物 (NO) 合成和生物可用性的障碍,因氧化应激和炎症而加剧,是AS发展的组成部分.
结论:
- 内皮功能障碍是多因子动脉样硬化的中心机制.
- 管理HT,HPL和HG等风险因素对于预防AS进展至关重要.
- 恢复氧化 (NO) 的生物可用性可能为抗AS治疗提供治疗策略.
相关概念视频
01:26Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
01:30Atherosclerosis I: Introduction
92
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92
01:30Coronary Artery Disease I: Introduction
60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60
01:30Peripheral Artery Disease I: Introduction
35
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
35
01:38Inflammation
55.3K
Overview
55.3K
01:28Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K